Izovag

Isoconazole Nitrate, the active ingredient in Izovag, is a azole antifungal presented as a vaginal formulation for vaginal use. It treats vulvovaginal candidiasis in women. GNH USA supplies Izovag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Izovag is an azole antifungal used to manage fungal infections of the vagina. - Vulvovaginal candidiasis: reduces fungal load and relieves itching, burning and discharge. - Acute candidal vaginitis: provides rapid symptom relief and eradicates the infection. - Recurrent yeast infection prophylaxis: helps prevent recurrence when used as directed.

Local application of Izovag may cause mild to moderate reactions.

Common Side Effects: - Vaginal irritation: mild burning or stinging sensation. - Itching: localized pruritus at the application site. - Discharge: increased vaginal secretions. - Unpleasant odor: temporary change in vaginal smell. - Mild allergic reaction: redness or rash. - Dryness: temporary vaginal dryness.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Anaphylaxis: rapid onset of systemic hypersensitivity. - Persistent severe irritation: prolonged burning or ulceration. - Secondary bacterial infection: signs of bacterial overgrowth. - Stevens‑Johnson syndrome: rare severe skin reaction. - Toxic epidermal necrolysis: extremely rare life‑threatening skin condition.

Before using Izovag, consider the following safety measures. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Allergy: avoid if hypersensitivity to isoconazole or other azoles is known. - Concurrent vaginal products: do not use with other intravaginal medications unless directed. - Immunocompromised patients: use with caution and under medical supervision. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Izovag may interact with other agents applied vaginally or systemically.

Major Interactions (Avoid): - Concurrent use of other vaginal antifungal agents: may increase local toxicity. - Systemic azole antifungals (e.g., ketoconazole): additive inhibition of fungal enzymes.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal efficacy. - Antibiotics affecting vaginal flora: could alter infection dynamics. - Hormonal contraceptives: monitor for reduced effectiveness, though evidence is limited.